CHRISTINE MCRAE: Open Payments
NPI 1225080609 · RICHARDSON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$828 in 42 payments from 14 companies in 2025. Trend: 2023 $304 · 2024 $780 · 2025 $828
Food & beverage: $828
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $170 |
| GlaxoSmithKline, LLC. | 7 | $115 |
| Exact Sciences Corporation | 4 | $112 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $90 |
| ABBVIE INC. | 4 | $82 |
| Novo Nordisk Inc | 4 | $73 |
| PFIZER INC. | 3 | $50 |
| Lilly USA, LLC | 2 | $34 |
| SANOFI PASTEUR INC. | 1 | $23 |
| Abbott Laboratories | 1 | $18 |
Products named: AIRSUPRA, Cologuard Collection Kit, Kerendia, VRAYLAR, TRELEGY ELLIPTA, NURTEC ODT, Wegovy, FARXIGA.
Industry payments across TX — which companies pay providers there.
